✦ LIBER ✦

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

✍ Scribed by Tudor Ciuleanu; Thomas Brodowicz; Christoph Zielinski; Joo Hang Kim; Maciej Krzakowski; Eckart Laack; Yi-Long Wu; Isabel Bover; Stephen Begbie; Valentina Tzekova; Branka Cucevic; Jose Rodrigues Pereira; Sung Hyun Yang; Jayaprakash Madhavan; Katherine P Sugarman; Patrick Peterson; William J John; Kurt Krejcy; Chandra P Belani

Book ID: 117305401
Publisher: The Lancet
Year: 2009
Tongue: English
Weight: 217 KB
Volume: 374
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(09)61497-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Maintenance therapy with pemetrexed plus

Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial

✍ Luis Paz-Ares; Filippo de Marinis; Mircea Dediu; Michael Thomas; Jean-Louis Pujo 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 244 KB

A multicenter, randomized, phase III stu

A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC)

✍ Roszkowski, Kazimierz; Pluzanska, Anna; Krzakowski, Maciej; Smith, Alexander Pet 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Gefitinib plus best supportive care in p

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

✍ Thatcher, Nick (author);Chang, Alex (author);Parikh, Purvish (author);Rodrigues 📂 Article 📅 2005 🏛 Elsevier BV 🌐 English ⚖ 158 KB

Pr4 ISEL: A Phase III survival study com

Pr4 ISEL: A Phase III survival study comparing gefitinib (IRESSA) plus best supportive care (BSC) with placebo plus BSC, in patients with advanced non-small-cell lung cancer (NSCLC) who had received one or two prior chemotherapy regimens

✍ Thatcher, N.; Chang, A.; Parikh, P.; Pemberton, K.; Archer, V. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Vinorelbine (VNR) plus best supportive c

Vinorelbine (VNR) plus best supportive care (BSC) vs. BSC in the treatment of advanced non-small cell lung cancer (NSCLC) elderly patients (PTS). Results of a phase III randomized trial

✍ Gridelli, C; Ianniello, GP; Maiorino, L; Brancaccio, L; Cigolari, S; Bilancia, D 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Quality of life in patients with advance

Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study

✍ Chandra P Belani; Thomas Brodowicz; Tudor E Ciuleanu; Maciej Krzakowski; Sung Hy 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 230 KB